Clinical Trials Arena on MSN
Tangram submits application to MHRA for TGM-312 Phase I/II clinical trial
Tangram Therapeutics has submitted a clinical trial application (CTA) to the Medicines and Healthcare products Regulatory ...
The Company expects to initiate first-in-human study in early 2026, with initial data anticipated H2 2026Clinical Trial Application (CTA) ...
Tangram Therapeutics plc has submitted a clinical trial application (CTA) to the U.K.’s Medicines and Healthcare products Regulatory Agency (MHRA) to initiate a phase I/II trial of TGM-312 for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback